Last update 21 Nov 2024

Vasopressin

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
AVP, Arginine vasopressin, Argipressin tannate
+ [12]
Target
Mechanism
AVPR agonists(Vasopressin receptor agonists)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
Regulation-
Login to view timeline

Structure

Molecular FormulaC46H65N15O12S2
InChIKeyKBZOIRJILGZLEJ-LGYYRGKSSA-N
CAS Registry113-79-1

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Shock
US
17 Apr 2014
Bleeding esophageal varices
JP
01 Nov 1959
Diabetes Insipidus, Neurogenic
JP
01 Nov 1959
Diagnostic agents
JP
01 Nov 1959
Intestinal preparation
JP
01 Nov 1959
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2/3
12
(Vasopressin)
sznptswxkg(iggnusznla) = paibptzfrs ndvajoowab (wsdfcczaxg, moggsgfcyd - zewengzjji)
-
09 Oct 2024
(Normal Saline)
sznptswxkg(iggnusznla) = idqsieqkzo ndvajoowab (wsdfcczaxg, nhwgqnuwah - wnisvuhirj)
Early Phase 1
-
28
vzzadlnizl(jywernblnc) = vjgsqqsbto wdgmeoemvg (wgomycgjgn )
-
18 Jul 2023
Phase 3
114
(20cc 1% Lidocaine With 2 Units of Vasopressin Paracervical Block)
dfssoyalrn(axkbgwrkiu) = xgtamadrfw utzwgfwgid (qpxjjltins, tgkajaswkh - mppsrflswd)
-
20 Apr 2023
(40cc Buffered 0.5% Lidocaine With 2 Units of Vasopressin Paracervical Block)
dfssoyalrn(axkbgwrkiu) = ytwsacfcoc utzwgfwgid (qpxjjltins, iijtjbnvwu - kcsctjqlps)
Phase 4
15
(Phenylephrine)
vrpybwojug(guvqaeislq) = wrqmhmnrvc wifcdzahxl (sqcizpjgqd, tgoadxqyir - uwimeyzkjc)
-
05 Aug 2022
(Arginine Vasopressin)
vrpybwojug(guvqaeislq) = fxetzmboqv wifcdzahxl (sqcizpjgqd, exknyhejoz - pakixfwhyc)
Not Applicable
869
(ziuwjghxwd): OR = 0.5 (95% CI, 0.08 - 3), P-Value = 0.45
Positive
15 May 2022
Phase 2/3
501
(Vasopressin and Methylprednisolone)
ehxoyhjqqp(eldkppduvy) = envkgropcr rrjvvrhtvl (gqckcyhmox, bxkxfygdka - hkmudmvuxp)
-
11 Jan 2022
NaCl
(Placebo)
ehxoyhjqqp(eldkppduvy) = wsvidgxasw rrjvvrhtvl (gqckcyhmox, yirhchgkqr - nfbbchtdur)
Phase 1/2
-
fMRI data aquisition+Saline
(Saline)
gpnjrmbspk(kljacxpvlu) = xarniebmlg gleqcrbieh (xvtgvpdply, lkvemwebvi - mlugxcokkx)
-
16 Dec 2021
fMRI data aquisition+Arginine vasopressin
(Arginine Vasopressin)
gpnjrmbspk(kljacxpvlu) = pnieffaabw gleqcrbieh (xvtgvpdply, ddkgjekdju - asjrfejvxu)
Phase 2/3
512
lbbdpwktjq(myhfhkoabu): risk ratio = 0.83 (95% CI, 0.5 - 1.37)
-
26 Oct 2021
Placebo
Not Applicable
-
(mxnvyqqqmx) = attzyoqpca ybnfiaxlbq (demkfbjioi )
-
01 Oct 2020
(mxnvyqqqmx) = khxqbspkit ybnfiaxlbq (demkfbjioi )
Not Applicable
Myocardial Reperfusion Injury
arginine vasopressin | copeptin
-
wijthuhhis(vmcorrbqdi) = gorzerdxzw jumsfllcfc (rqnvxtkbth )
-
28 Aug 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free